MRVI

Maravai Lifesciences Holdings Stock Analysis

AI Rating

Low
  • Quality5/10
  • Growth↓ 2/10
  • Value↓ 0/10
Maravai Lifesciences Holdings sales and earnings growth
MRVI Growth
Fair
  • Revenue Y/Y↓ -28.34%
  • EPS Y/Y↑ 14.29%
  • FCF Y/Y↓ -365.01%
Maravai Lifesciences Holdings gross and profit margin trends
MRVI Profitability
Low
  • Gross margin ↑ 18.30%
  • EPS margin↓ -70.40%
  • ROIC 5Y↓ 14.80%
Maravai Lifesciences Holdings net debt vs free cash flow
MRVI Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 4.6
  • Interest coverage↓ -4.0

Maravai Lifesciences Holdings stock volatility is in-line with the overall market. We give it a Poor risk rating.

More Biotechnology stocks ↗